Giuseppe Occhino

Giuseppe Occhino

Auto-generated profile, based on publicly available information

Giuseppe Occhino

Bicocca Bioinformatics, Biostatistics and Bioimaging Centre—B4, School of Medicine and Surgery, University of Milano-Bicocca , Via Cadore, 48., 20900 Monza , Italy

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2022 in European Journal of Cardiovascular Nursing
Verified
Journal Article
Closed access
PDF file
GLGiulia Locatelli
Giulia Locatelli
VZValentina Zeffiro
Valentina Zeffiro
GOGiuseppe Occhino
Giuseppe Occhino
PRPaola Rebora
Paola Rebora
GCGABRIELE Caggianelli
GABRIELE Caggianelli
EVErcole Vellone
Ercole Vellone
Caregiver characteristics and behaviours are associated with patients’ and caregivers’ outcomes. However, there is scarce evidence on interventions aimed at improving caregiver contribution (CC) to patient self-care, caregiver self-efficacy, and caregiver preparedness in heart failure (HF). This study aims to evaluate the effect of Motivational Interviewing (MI) on CC to patient self-care, caregiver self-efficacy, and caregiver preparedness in HF. This is a secondary outcome analysis of MOTIVATE-HF randomized controlled trial. Caregivers of patients with HF were randomized into three arms: Arm 1 (MI for patients), Arm 2 (MI for patients and caregivers), and Arm 3 (standard care). The intervention consisted of one MI session plus three telephone contacts. Data were collected at baseline and after 3, 6, 9, and 12 months. A total of 510 patient and caregiver (median age 54 years, 76% females) dyads were enrolled, 235 caregivers and 238 patients completed the study until 12 months. Caregiver contribution to self-care maintenance and management and caregiver preparedness significantly improved over time, but without significant differences among the three arms. At 9 months, caregiver self-efficacy improved more in Arm 2 than Arm 3 [difference: 8.36, 95% confidence interval (CI) (3.13; 13.59), P = 0.001]. This improvement remained significant also at linear mixed model [ β^ = 1.39, 95% CI (0.02; 2.75), P = 0.046]. Motivational Interviewing did not improve CC to patient self-care and caregiver preparedness. However, it increased caregiver self-efficacy, which is known to be a powerful mediator of CC to self-care. Clinicaltrials.gov: NCT02894502.

1 February 2022 in Journal of Pain and Symptom Management
Verified
Journal Article
Closed access
GCGabriele Caggianelli
Gabriele Caggianelli
PIPaolo Iovino
Paolo Iovino
PRPaola Rebora
Paola Rebora
GOGiuseppe Occhino
Giuseppe Occhino
VZValentina Zeffiro
Valentina Zeffiro
EVErcole Vellone
Ercole Vellone

4 June 2021 in ESC Heart Failure
Verified
Journal Article
Open access
PDF file
PIPaolo Iovino
Paolo Iovino
PRPaola Rebora
Paola Rebora
GOGiuseppe Occhino
Giuseppe Occhino
VZValentina Zeffiro
Valentina Zeffiro
GCGABRIELE Caggianelli
GABRIELE Caggianelli
EVErcole Vellone
Ercole Vellone
Aims Intense health-care service use and high mortality are common in heart failure (HF) patients. This secondary analysis of the MOTIVATE-HF trial investigates the effectiveness of motivational interviewing (MI) in reducing health-care service use (e.g. emergency service use and hospitalizations) and all-cause mortality. Methods and results This study used a randomized controlled trial. Patients and caregivers were randomized to Arm 1 (MI for patients), Arm 2 (MI for patients and caregivers), or Arm 3 (control group). Data were collected at baseline and at 3, 6, 9, and 12 months. Face-to-face MI plus three telephone calls were performed in Arms 1 and 2. The sample consisted of 510 patient (median age 74 years, 58% male patients) and caregiver dyads (median age 55 years, 75% female patients). At 12 months, 16.1%, 17%, and 11.2% of patients used health-care services at least once in Arms 1, 2, and 3, respectively, without significant difference. At 3 months, 1.9%, 0.6%, and 5.1% of patients died in Arms 1, 2, and 3, respectively. Mortality was lower in Arm 2 vs. Arm 3 at 3 months [hazard ratio (HR) = 0.112, 95% CI: 0.014–0.882, P = 0.04]; no difference was found at subsequent follow-ups. Mortality was lower in Arm 1 vs. Arm 3 at 3 months but did not reach statistical significance (HR = 0.38, 95% CI: 0.104–1.414, P = 0.15). Conclusion This study suggests that MI reduces mortality in patients with HF if caregivers are included in the intervention. Further studies with a stronger intervention and longer follow-up are needed to clarify the benefits of MI on health-care service use and mortality.